Not intended for US and UK audiences BI 765423 has been developed to target IL-11, a key driver of fibrosis…
Company has built one of the largest proprietary extracellular matrix (ECM) datasets spanning fibrosis and solid tumors January 08, 2026…
The approval marks the first new treatment option for people living with progressive pulmonary fibrosis (PPF) in more than five…
The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift…